Immunomodulatory properties of human serum immunoglobulin A: Anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells

Clinical and Experimental Immunology

Volumn 140, Issue 3, 2005, Pages 478-490

  Olas, Katja ^a   Butterweck, H ^a   Teschner, W ^a   Schwarz, H P ^a   Reipert, B M ^a  

^a BAXTER BIOSCIENCE   (Austria)

Author keywords

Anti inflammatory cytokines; Human monocytes; Human PBMC; Pro inflammatory cytokines; Serum IgA

Indexed keywords

CHEMOKINE; CYTOKINE; ENDOTOXIN; IMMUNOGLOBULIN A; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PURIFICATION; UPREGULATION;

CELLS, CULTURED; CHEMOKINE CCL2; CYTOKINES; DOWN-REGULATION; HUMANS; IMMUNOGLOBULIN A; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MACROPHAGE INFLAMMATORY PROTEIN-1; MONOCYTES; RECEPTORS, INTERLEUKIN-1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 20444507292     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02779.x     Document Type: Article

References (66)

1. Kerr MA. The structure and function of human IgA. Biochem J 1990; 271:285-96.
2. van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG. IgA and the IgA Fc receptor. Trends Immunol 2001; 22:205-11.
3. Arulanandam BP, Raeder RH, Nedrud JG, Bucher DJ, Le J, Metzger DW. IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection. J Immunol 2001; 166:226-31.
4. McGhee JR, Mestecky J, Elson CO, Kiyono H. Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol 1989; 9:175-99.
5. Morton HC, Brandtzaeg P. CD89: the human myeloid IgA Fc receptor. Arch Immunol Ther Exp (Warsz) 2001; 49:217-29.
6. Kutteh WH, Prince SJ, Mestecky J. Tissue origins of human polymeric and monomeric IgA. J Immunol 1982; 128:990-5.
7. Kett K, Brandtzaeg P, Radl J, Haaijman JJ. Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol 1986; 136:3631-5.
8. Lamm ME. Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol 1997; 51:311-40.
9. Honorio-Franca AC, Launay P, Carneiro-Sampaio MM, Monteiro RC. Colostral neutrophils express Fc alpha receptors (CD89) lacking gamma chain association and mediate noninflammatory properties of secretory IgA. J Leukoc Biol 2001; 69:289-96.
10. Heystek HC, Moulon C, Woltman AM, Garonne P, van Kooten C. Human immature dendritic cells efficiently bind and take up secretory IgA without the induction of maturation. J Immunol 2002; 168:102-7.
11. Pleass RJ, Areschoug T, Lindahl G, Woof JM. Streptococcal IgA-binding proteins bind in the Calpha 2-Calpha 3 interdomain region and inhibit binding of IgA to human CD89. J Biol Chem 2001; 276:8197-204.
12. Russell MW, Mansa B. Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound, IgA. Scand J Immunol 1989; 30:175-83.
13. Russell MW, Sibley DA, Nikolova EB, Tomana M, Mestecky J. IgA antibody as a non-inflammatory regulator of immunity. Biochem Soc Trans 1997; 25:466-70.
14. Russell MW, Reinholdt J, Kilian M. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation. Eur J Immunol 1989; 19:2243-9.
15. Janoff EN, Fasching C, Orenstein JM, Rubins JB, Opstad NL, Dalmasso AP. Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes. J Clin Invest 1999; 104:1139-47.
16. Zhang W, Lachmann PJ. Neutrophil lactoferrin release induced by IgA immune complexes can be mediated either by Fc alpha receptors or by complement receptors through different pathways. J Immunol 1996; 156:2599-606.
17. Moura IC, Centelles MN, Arcos-Fajardo M et al. Identification of the transferrin receptor as a novel immunoglobulin (Ig) A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 2001; 194:417-25.
18. van Egmond M, van Garderen E, van Spriel AB et al. FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat Med 2000; 6:680-5.
19. Mazengera RL, Kerr MA. The specificity of the IgA receptor purified from human neutrophils. Biochem J 1990; 272:159-65.
20. Pleass RJ, Andrews PD, Kerr MA, Woof JM. Alternative splicing of the human IgA Fc receptor CD89 in neutrophils and eosinophils. Biochem J 1996; 318:771-7.
21. Monteiro RC, Cooper MD, Kubagawa H. Molecular heterogeneity of Fc alpha receptors detected by receptor- specific monoclonal antibodies. J Immunol 1992; 148:1764-70.
22. Geissmann F, Launay P, Pasquier B et al. A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes. J Immunol 2001; 166:346-52.
23. Patry C, Sibille Y, Lehuen A, Monteiro RC. Identification of Fc alpha receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages. J Immunol 1996; 156:4442-8.
24. Morton HC, van Egmond M, van de Winkel JG. Structure and function of human IgA Fc receptors (Fc alpha R). Crit Rev Immunol 1996; 16:423-40.
25. Foreback JL, Remick DG, Crockett-Torabi E, Ward PA. Cytokine responses of human blood monocytes stimulated with Igs. Inflammation 1997; 21:501-17.
26. Ferreri NR, Howland WC, Spiegelberg HL. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE. J Immunol 1986; 136:4188-93.
27. Patry C, Herbelin A, Lehuen A, Bach JF, Monteiro RC. Fc alpha receptors mediate release of tumour necrosis factor-alpha and interleukin-6 by human monocytes following receptor aggregation. Immunology 1995; 86:1-5.
28. Wolf HM, Fischer MB, Puhringer H, Samstag A, Vogel E, Eibl MM. Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-6) in human monocytes. Blood 1994; 83:1278-88.
29. Wolf HM, Hauber I, Gulle H et al. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89) -mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes. Clin Exp Immunol 1996; 105:537-43.
30. Nikolova EB, Russell MW. Dual function of human IgA antibodies: inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL-8-stimulated cells. J Leukoc Biol 1995; 57:875-82.
31. Cohn EJ, Strong LE, Hughes WI Jr, Mulford DJ, Ashworth JN, Melin M, Taylor HL. Preparation and properties of serum and palsma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chem Soc 1946; 68:459-75.
32. Bøyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Laboratory Invest 1968; 21:77.
33. Heumann D, Gallay P, Barras C et al. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J Immunol 1992; 148:3505-12.
34. Gessani S, Testa U, Varano B et al. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors. J Immunol 1993; 151:3758-66.
35. Liebler JM, Kunkel SL, Burdick MD, Standiford TJ, Rolfe MW, Stricter RM. Production of IL-8 and monocyte chemotactic peptide-1 by peripheral blood monocytes. Disparate responses to phytohemagglutinin and lipopolysaccharide. J Immunol 1994; 152:241-9.
36. Kalinski P, Vieira PL, Schuitemaker JH, de Jong EC, Kapsenberg ML. Prostaglandin E (2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 2001; 97:3466-9.
37. Camoglio L, Juffermans NP, Peppelenbosch M et al. Contrasting roles of IL-12p40 and IL-12p35 in the development of hapten-induced colitis. Eur J Immunol 2002; 32:261-9.
38. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 33:305-15.
39. Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 1995; 38:151-60.
40. Tracey KJ, Fong Y, Hesse DG et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662-4.
41. Stokkers PC, Camoglio L, Van Deventer SJ. Tumor necrosis factor (TNF) in inflammatory bowel disease: gene polymorphisms, animal models, and potential for anti-TNF therapy. J Inflamm 1995; 47:97-103.
42. Matsuno H, Yudoh K, Katayama R et al. The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera. Rheumatology 2002; 41:329-37.
43. Mackay F, Browning JL, Lawton P et al. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology 1998; 115:1464-75.
44. Bargetzi MJ, Lantz M, Smith CG et al. Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans. Cancer Res 1993; 53:4010-3.
45. Millet I, Panaye G, Revillard JP. Expression of receptors for IgA on mitogen-stimulated human T lymphocytes. Eur J Immunol 1988; 18:621-6.
46. Millet I, Briere F, de Vries J, Revillard JP. Up-regulation of receptors for IgA on activated human B lymphocytes. Immunol Lett 1988; 19:153-7.
47. Cross JT, Benton HP. The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus. Inflamm Res 1999; 48:255-61.
48. Finck BK, Chan B, Wofsy D. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest 1994; 94:585-91.
49. Kitani A, Hara M, Hirose T et al. Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin Exp Immunol 1992; 88:75-83.
50. Miret C, Font J, Molina R et al. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus. Anticancer Res 2001; 21:3053-9.
51. Ronnelid J, Tejde A, Mathsson L, Nilsson-Ekdahl K, Nilsson B. Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE. Ann Rheum Dis 2003; 62:37-42.
52. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 1994; 179:305-10.
53. Launay P, Patry C, Lehuen A, Pasquier B, Blank U, Monteiro RC. Alternative endocytic pathway for immunoglobulin A Fc receptors (CD89) depends on the lack of FcRgamma association and protects against degradation of bound ligand. J Biol Chem 1999; 274:7216-25.
54. Arend WP, Leung DY. IgG induction of IL-1 receptor antagonist production by human monocytes. Immunol Rev 1994; 139:71-8.
55. Gorter A, Hiemstra PS, Leijh PC et al. IgA- and secretory IgA-opsonized S. aureus induce a respiratory burst and phagocytosis by polymorphonuclear leucocytes. Immunology 1987; 61:303-9.
56. Shen L, Collins J. Monocyte superoxide secretion triggered by human IgA. Immunology 1989; 68:491-6.
57. Stewart WW, Mazengera RL, Shen L, Kerr MA. Unaggregated serum IgA binds to neutrophil Fc alpha R at physiological concentrations and is endocytosed but cross-linking is necessary to elicit a respiratory burst. J Leukoc Biol 1994; 56:481-7.
58. Shen L. A monoclonal antibody specific for immunoglobulin A receptor triggers polymorphonuclear neutrophil superoxide release. J Leukoc Biol 1992; 51:373-8.
59. Gorter A, Hiemstra PS, Leijh PC, van Es LA, Daha MR. Stimulation of human polymorphonuclear leukocytes by serum IgA or secretory IgA. Adv Exp Med Biol 1987; 216B:1325-31.
60. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989; 142:2393-400.
61. Deviere J, Content J, Denys C et al. Immunoglobulin A and interleukin 6 form a positive secretory feedback loop: a study of normal subjects and alcoholic cirrhotics. Gastroenterology 1992; 103:1296-301.
62. Deviere J, Vaerman JP, Content J et al. IgA triggers tumor necrosis factor alpha secretion by monocytes: a study in normal subjects and patients with alcoholic cirrhosis. Hepatology 1991; 13:670-5.
63. Polat GL, Laufer J, Fabian I, Passwell JH. Cross-linking of monocyte plasma membrane Fc alpha, Fc gamma or mannose receptors induces TNF production. Immunology 1993; 80:287-92.
64. Shen L, Collins JE, Schoenborn MA, Maliszewski CR. Lipopolysaccharide and cytokine augmentation of human monocyte IgA receptor expression and function. J Immunol 1994; 152:4080-6.
65. Reterink TJ, van Zandbergen G, van Egmond M et al. Size-dependent effect of IgA on the IgA Fc receptor (CD89). Eur J Immunol 1997; 27:2219-24.
66. van der Boog PJ, van Zandbergen G, de Fijter JW et al. Fc alpha RI/CD89 circulates in human serum covalently linked to IgA in a polymeric state. J Immunol 2002; 168:1252-8.